Literature DB >> 29234887

iPS cells in the study of PD molecular pathogenesis.

Melanie M Cobb1, Abinaya Ravisankar1, Gaia Skibinski1, Steven Finkbeiner2,3,4,5.   

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease and its pathogenic mechanisms are poorly understood. The majority of PD cases are sporadic but a number of genes are associated with familial PD. Sporadic and familial PD have many molecular and cellular features in common, suggesting some shared pathogenic mechanisms. Induced pluripotent stem cells (iPSCs) have been derived from patients harboring a range of different mutations of PD-associated genes. PD patient-derived iPSCs have been differentiated into relevant cell types, in particular dopaminergic neurons and used as a model to study PD. In this review, we describe how iPSCs have been used to improve our understanding of the pathogenesis of PD. We describe what cellular and molecular phenotypes have been observed in neurons derived from iPSCs harboring known PD-associated mutations and what common pathways may be involved.

Entities:  

Keywords:  Alpha-synuclein; Autophagy; Induced pluripotent stem cell (iPSC); Neurodegeneration; Parkinson’s disease

Mesh:

Substances:

Year:  2017        PMID: 29234887      PMCID: PMC5997490          DOI: 10.1007/s00441-017-2749-y

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  179 in total

Review 1.  Oxidative stress and nitration in neurodegeneration: cause, effect, or association?

Authors:  Harry Ischiropoulos; Joseph S Beckman
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

2.  Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations.

Authors:  Frank Soldner; Josée Laganière; Albert W Cheng; Dirk Hockemeyer; Qing Gao; Raaji Alagappan; Vikram Khurana; Lawrence I Golbe; Richard H Myers; Susan Lindquist; Lei Zhang; Dmitry Guschin; Lauren K Fong; B Joseph Vu; Xiangdong Meng; Fyodor D Urnov; Edward J Rebar; Philip D Gregory; H Steve Zhang; Rudolf Jaenisch
Journal:  Cell       Date:  2011-07-14       Impact factor: 41.582

3.  Mitochondrial rejuvenation after induced pluripotency.

Authors:  Steven T Suhr; Eun Ah Chang; Jonathan Tjong; Nathan Alcasid; Guy A Perkins; Marcelo D Goissis; Mark H Ellisman; Gloria I Perez; Jose B Cibelli
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240

4.  Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression.

Authors:  Peter Reinhardt; Benjamin Schmid; Lena F Burbulla; David C Schöndorf; Lydia Wagner; Michael Glatza; Susanne Höing; Gunnar Hargus; Susanna A Heck; Ashutosh Dhingra; Guangming Wu; Stephan Müller; Kathrin Brockmann; Torsten Kluba; Martina Maisel; Rejko Krüger; Daniela Berg; Yaroslav Tsytsyura; Cora S Thiel; Olympia-Ekaterini Psathaki; Jürgen Klingauf; Tanja Kuhlmann; Marlene Klewin; Heiko Müller; Thomas Gasser; Hans R Schöler; Jared Sterneckert
Journal:  Cell Stem Cell       Date:  2013-03-07       Impact factor: 24.633

Review 5.  Back and forth in time: Directing age in iPSC-derived lineages.

Authors:  Daniela Cornacchia; Lorenz Studer
Journal:  Brain Res       Date:  2015-11-17       Impact factor: 3.252

Review 6.  Intrinsically disordered proteins in human diseases: introducing the D2 concept.

Authors:  Vladimir N Uversky; Christopher J Oldfield; A Keith Dunker
Journal:  Annu Rev Biophys       Date:  2008       Impact factor: 12.981

Review 7.  Translation: screening for novel therapeutics with disease-relevant cell types derived from human stem cell models.

Authors:  Stephen J Haggarty; Roy H Perlis
Journal:  Biol Psychiatry       Date:  2013-07-19       Impact factor: 13.382

8.  Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells.

Authors:  Edward D Plowey; Salvatore J Cherra; Yong-Jian Liu; Charleen T Chu
Journal:  J Neurochem       Date:  2008-01-07       Impact factor: 5.372

9.  Genetic basis of Parkinson's disease: inheritance, penetrance, and expression.

Authors:  Claudia Schulte; Thomas Gasser
Journal:  Appl Clin Genet       Date:  2011-06-01

10.  alpha-Synuclein and neuronal cell death.

Authors:  Mark R Cookson
Journal:  Mol Neurodegener       Date:  2009-02-04       Impact factor: 14.195

View more
  13 in total

Review 1.  Cell death assays for neurodegenerative disease drug discovery.

Authors:  Jeremy W Linsley; Terry Reisine; Steven Finkbeiner
Journal:  Expert Opin Drug Discov       Date:  2019-06-10       Impact factor: 6.098

2.  Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.

Authors:  Sarah Logan; Thiago Arzua; Scott G Canfield; Emily R Seminary; Samantha L Sison; Allison D Ebert; Xiaowen Bai
Journal:  Compr Physiol       Date:  2019-03-14       Impact factor: 9.090

Review 3.  Induced pluripotent stem cells for neural drug discovery.

Authors:  Atena Farkhondeh; Rong Li; Kirill Gorshkov; Kevin G Chen; Matthew Might; Steven Rodems; Donald C Lo; Wei Zheng
Journal:  Drug Discov Today       Date:  2019-01-18       Impact factor: 7.851

Review 4.  Cellular models of alpha-synuclein toxicity and aggregation.

Authors:  Marion Delenclos; Jeremy D Burgess; Agaristi Lamprokostopoulou; Tiago F Outeiro; Kostas Vekrellis; Pamela J McLean
Journal:  J Neurochem       Date:  2019-07-30       Impact factor: 5.372

Review 5.  From Neuronal Differentiation of iPSCs to 3D Neuro-Organoids: Modelling and Therapy of Neurodegenerative Diseases.

Authors:  Matteo Bordoni; Federica Rey; Valentina Fantini; Orietta Pansarasa; Anna Maria Di Giulio; Stephana Carelli; Cristina Cereda
Journal:  Int J Mol Sci       Date:  2018-12-10       Impact factor: 5.923

6.  Pueraria lobata and Daidzein Reduce Cytotoxicity by Enhancing Ubiquitin-Proteasome System Function in SCA3-iPSC-Derived Neurons.

Authors:  I-Cheng Chen; Kuo-Hsuan Chang; Yi-Jing Chen; Yi-Chun Chen; Guey-Jen Lee-Chen; Chiung-Mei Chen
Journal:  Oxid Med Cell Longev       Date:  2019-10-07       Impact factor: 6.543

7.  The C-Terminal Domain of LRRK2 with the G2019S Substitution Increases Mutant A53T α-Synuclein Toxicity in Dopaminergic Neurons In Vivo.

Authors:  Noémie Cresto; Camille Gardier; Marie-Claude Gaillard; Francesco Gubinelli; Pauline Roost; Daniela Molina; Charlène Josephine; Noëlle Dufour; Gwenaëlle Auregan; Martine Guillermier; Suéva Bernier; Caroline Jan; Pauline Gipchtein; Philippe Hantraye; Marie-Christine Chartier-Harlin; Gilles Bonvento; Nadja Van Camp; Jean-Marc Taymans; Karine Cambon; Géraldine Liot; Alexis-Pierre Bemelmans; Emmanuel Brouillet
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

Review 8.  Representing Diversity in the Dish: Using Patient-Derived in Vitro Models to Recreate the Heterogeneity of Neurological Disease.

Authors:  Layla T Ghaffari; Alexander Starr; Andrew T Nelson; Rita Sattler
Journal:  Front Neurosci       Date:  2018-02-09       Impact factor: 4.677

9.  Bioink Composition and Printing Parameters for 3D Modeling Neural Tissue.

Authors:  Valentina Fantini; Matteo Bordoni; Franca Scocozza; Michele Conti; Eveljn Scarian; Stephana Carelli; Anna Maria Di Giulio; Stefania Marconi; Orietta Pansarasa; Ferdinando Auricchio; Cristina Cereda
Journal:  Cells       Date:  2019-08-05       Impact factor: 6.600

Review 10.  Functional genomics, genetic risk profiling and cell phenotypes in neurodegenerative disease.

Authors:  Steven Finkbeiner
Journal:  Neurobiol Dis       Date:  2020-09-23       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.